Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD

Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoietic stem cell transplantation (allo-HSCT), but the effectiveness of this monotherapy is still very low. A possible mechanism of resistance...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Sun, Jianlin, Chen, Zhuoqing, Qiao, Yuhang, Li, Jiangwei, Hu, Guoliang, Hu, Hongmei, Ning, Bin, Zhang, Liangding, Hu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047076/
https://www.ncbi.nlm.nih.gov/pubmed/33868266
http://dx.doi.org/10.3389/fimmu.2021.639217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047076/
https://www.ncbi.nlm.nih.gov/pubmed/33868266
http://dx.doi.org/10.3389/fimmu.2021.639217

Ejemplares similares